enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Donanemab - Wikipedia

    en.wikipedia.org/wiki/Donanemab

    Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. [1] [2] Donanemab was developed by Eli Lilly and Company. [3] [4] The most common side effects include amyloid-related imaging abnormalities and headache. [2] Donanemab was approved for medical use in the United States in July 2024.

  3. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. [31] [32] Donanemab was developed by Eli Lilly and Company. [33] [34] The most common side effects include amyloid-related imaging abnormalities and headache. [32] Donanemab was approved for medical use in the United States in ...

  4. Donanemab – what we know about the latest Alzheimer’s drug

    www.aol.com/donanemab-know-latest-alzheimer-drug...

    Donanemab is given to patients via an intravenous drip once every four weeks. Lilly has said that some patients can complete their course of treatment in as little as six months once their amyloid ...

  5. FDA approves Alzheimer’s treatment that has been shown to ...

    www.aol.com/news/fda-approves-alzheimer...

    The drug donanemab, which will be sold under the brand name Kisunla, is a monoclonal antibody infusion given every four weeks. ... a neurologist at the Mayo Clinic.

  6. Everything we know about breakthrough Alzheimer’s drug Donanemab

    www.aol.com/everything-know-breakthrough...

    The study, published in the Journal of the American Medical Association, concluded that after 76 weeks of treatment, Donanemab was able to slow clinical decline by 35.1% in people with early ...

  7. Monoclonal antibody therapy - Wikipedia

    en.wikipedia.org/wiki/Monoclonal_antibody_therapy

    [8] [9] Treatment also had to be tailored to each individual patient, which was impracticable in routine clinical settings. [citation needed] Four major antibody types that have been developed are murine, chimeric, humanised and human. Antibodies of each type are distinguished by suffixes on their name. [citation needed]

  8. US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10

    www.aol.com/news/us-fda-panel-discuss-eli...

    Lilly's donanemab was declined accelerated approval by the FDA in January 2023, and on March 8, the agency said it would hold a meeting of its advisers to discuss the drug, further delaying its ...

  9. Animal-assisted therapy - Wikipedia

    en.wikipedia.org/wiki/Animal-assisted_therapy

    Animal-assisted therapy is an alternative or complementary type of therapy that includes the use of animals in a treatment. [4] [5] It falls under the realm of animal-assisted intervention, which encompasses any intervention in the studio that includes an animal in a therapeutic context such as emotional support animals, service animals trained to assist with daily activities, and animal ...